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Abstract
The objective of this study was to estimate the association between changes in health care expenditures relative
to changes in health risk status for employers of all sizes. Repeat health risk assessments (HRAs) were obtained
from 50,005 employees and spouses with 2 years of health plan enrollment, and from 37,559 employees and
spouses with 3 years of enrollment in employer-sponsored medical coverage. Changes in health care expenditures
were measured from the year before completion of the first HRA to the years before and after the completion of
the second HRA. Propensity score weighting was used to adjust for those who did not repeat the HRA so results
could be extrapolated to the larger population. Propensity score weighted multiple regression analyses were used
to estimate the relationship between changes in health care expenditures with changes in risk status for 9 risk
categories. Significantly higher health care expenditures were associated with those who moved from low risk to
medium or high risk, compared to those who remained low risk. Expenditure reductions estimated for those who
improved their health status from high risk to medium or low risk were not statistically significant. This study is
unique because of its large sample size, its use of data from a wide range of employer sizes, and its efforts to
extend generalizability to those who did not complete both HRAs. These results demonstrate that the potential for
short-term health care savings may be greater for programs that help maintain low risk than for programs focused
on risk reduction. (Population Health Management 2014;17:297–305)
Introduction
Many employers sponsor employee health manage-ment programs to help contain health care costs. These
programs include a wide range of educational and behavioral
change efforts that are offered to employees and spouses
across employers of all sizes. A 2010 national employer
survey by the Kaiser Foundation found that 74% of em-
ployers offering health care benefits also sponsored at least 1
wellness program, an increase from 58% of employers in
2009. The Kaiser study noted that most of this change was
driven by small employers adopting Web-based wellness
resources in 2010.1 According to the US Census Bureau, at
least 50% of all US employees work within small employer
environments (ie, fewer than 500 employees).2 Nevertheless,
although wellness options have continued to expand for em-
ployees of small to medium-sized firms, program evaluations
and subsequent scientific reports tend to focus on medium and
large employer groups.1,3,4
With the continued expansion of health management pro-
gramming, there is an ongoing interest in documenting pop-
ulation health improvement and economic returns from these
programmatic investments. Despite several decades of re-
search on these topics, shortcomings in the research methods,
small sample sizes, the use of single employer evaluations, a
wide range of program designs, and a lack of consistency
across studies have hampered conclusions about the effec-
tiveness and/or cost-benefit of these programs.5 Numerous
studies, most being cross-sectional in design, have docu-
mented that health risks are associated with higher health
1Advanced Analytics, Optum, Ann Arbor, Michigan.
2Health Economics Outcome Research, Optum, Minneapolis, Minnesota.
3Consumer Solutions Group, Optum, Phoenix, Arizona.
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care expenditures in employee and spouse populations.6–13
Studies also show that health management programs of
various designs may result in health improvements for se-
lected health risks (eg, physical activity, nutrition, weight)
and/or overall health risk status over time.14–19
Evaluations of the economic benefits resulting from health
management programs are generally based on the hypothesis
that high rates of participation are necessary to generate
savings. Generally, it takes 3 to 5 years for such savings to
materialize.3,5,17,20,21 Fewer longitudinal studies have focused
on the mechanism and/or timing of cost savings related to
reductions of measured health risks and/or in the maintenance
of those currently at low risk.
It is well documented in the scientific literature that costs
positively correlate with changes in risks—as risks improve,
health care costs often decrease and as risks get worse, costs
tend to increase.22–26 More recently, studies have included
larger populations, combined data from several large em-
ployers, and have increased the precision of the timing for cost
changes following risk changes.18,19 To date, however, the
authors of the present study could find no studies including
small and medium-sized employers. In addition, methods have
been lacking that would address selection bias related to
having highly motivated repeat health risk assessment (HRA)
participants. The purpose of this study is to estimate the as-
sociation between changes in health care expenditures relative
to changes in health risk status for employers of all sizes,
generalizing to all employees and spouses regardless of
whether an HRA was completed.
Methods
Study design and sample selection
This study was a retrospective cohort analysis using individual-
level, self-reported data obtained from 2 consecutive annual
HRAs. These HRAs were completed by insured employees,
spouses, and significant others from across Optum’s em-
ployer client book of business. Inclusion criteria limited
the study sample to those 18 to 63 years of age at their first
HRA and to those who had completed their second HRAs
between May 2009 and May 2011. The elapsed time be-
tween the first and second HRA must have been between
270 and 450 days. Most sample members had medical and
pharmacy covered by UnitedHealthcare Insurance Company
(84%); another 16% were covered by other health plans. For
the first analysis, HRA repeaters were continuously enrolled
in their health plan for 2 years, with no monthly gaps from
the year prior to the first HRA to the year prior to the second
HRA. For the second analysis, HRA repeaters were con-
tinuously enrolled for 3 years, from the year before the first
HRA was taken to the year after the second HRA was
completed. Members with evidence of maternity services
were excluded from this analysis. About 80% of employers
offered additional health coaching options. To maintain a
consistent program intensity across employee/spouse par-
ticipant populations, those with documented health coaching
participation also were excluded (about 20%).
To minimize selection bias that might occur if HRA re-
peaters were significantly different than those who did not
complete 2 HRAs, a cohort of insured employees and
spouses who completed 0 or 1 HRA (ie, those who were
eligible for but did not complete 2 HRAs) also was selected.
Their data were used to generate a propensity score case
weight that was applied to those who completed 2 HRAs to
make the data from those who completed 2 HRAs better
resemble all employees regardless of whether HRAs were
completed. Methods for generating the case weight are de-
scribed in a following section. HRA non-completers/non-
repeaters must have otherwise met the same criteria as those
with repeat HRAs to be included in the study.
Definition of health risks
The University of Michigan Health Management Research
Center HRA was administered online and included questions
about lifestyle and behavioral health risks, biometric factors,
and health status.27 The following 9 health risks were included
in this study: alcohol, blood pressure (BP), body weight, cho-
lesterol, medication/drug use for relaxation, nutrition, physical
activity, stress, and smoking. All survey responses were self-
reported; however, values from biometric screenings were
utilized if measured within 30 days of the HRA completion
date, as occurred in about 10% of respondents. The 9 health
risks were dichotomized to denote either higher risk and lower
risk groups as follows: alcohol:> 14 drinks/wk (men);> 7
drinks/wk (women); BP: systolic BP> 119 or diastolic BP>
79mm Hg; cholesterol:> 199mg/dL; drug use for relaxation:
sometimes/almost every day; physical activity:< 1 time/wk;
smoking: current; nutrition:< 3 servings/day fruit/vegetable/
fiber; stress: some/a lot; and weight: body mass index< 18.5
or> 24.9. Of note, the research team used at-risk categories that
included those at moderate and high severity risk levels—an
approach commonly used in population health management
strategies. Based on the number of risk factors where the re-
spondent was at higher health risk, individuals were subse-
quently grouped into the following overall risk status levels for
the analysis: high risk indicates the individual was at higher risk
for 4–9 risks, medium risk indicates he or she was at higher risk
for 3 risk factors, and low risk indicates the respondent was at
higher risk for 0–2 risk factors.The research team thenobserved
whether samplemembersmovedbetween these low-,medium-,
or high-risk categories over time. These movements were then
associated with increases or decreases in health care expendi-
tures by undertaking propensity score weighted statistical an-
alyses that are described in a following section.
Determinants of health care costs
Total allowable health care expenditures were calculated in
US dollars for each sample member, including all inpatient,
outpatient, professional, and pharmacy costs, for the year
prior to the first HRA, the year prior to the second HRA, and
the year after the second HRA was completed. Allowed health
care costs (including plan payment, member payment, and
coordination of benefits) were utilized because allowed health
care costs are impacted to a lesser degree by differences in
employer health care paid benefit structures, or by changes in
benefit structures that may occur over time. All health care
costs were adjusted to May 2011 dollars using the medical
care services component in the Consumer Price Index.
Covariates
Covariates were included in the weighted regression an-
alyses to estimate relationships between changes in health
care expenditures and changes in risk so that the research
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team could differentiate between the impact of changing risks
versus other factors that also may influence health care ex-
penditures. These covariates included measures of demo-
graphics, health status, and other characteristics self-reported
on the HRA, or were taken from health plan eligibility and
claims files. Demographic variables included measures of the
respondent’s age, sex, race, education level, employee status,
and employer size. Age and education were each stratified into
4 groups (age: 18–34, 35–44, 45–54, and 55–63 years; edu-
cation: high school graduate or less, some college, college
graduate, and graduate school). Race was stratified into 5
groups (white, black, Hispanic, Asian, and other). Employer
size was stratified into 3 groups by number of employees
(small< 1000 employees; medium 1000–9999 employees; and
large ‡ 10,000 employees) and employee status was stratified
into 2 groups (employee and spouse/significant others).
Covariates measured from health plan membership or
claims data included the individual’s health plan type, the
ratio of paid-to-allowed health care costs covered by the
respondents’ insurance, an indicator of the existence of any
diagnosis or procedure associated with complex medical
conditions (see the following description) and the calcu-
lated Charlson comorbidity index (CCI).28 The CCI is a
measure of the risk of 1-year all-cause mortality attributable
to selected comorbidities that also has been shown to be
highly predictive of morbidity and health care expenditures.
Information about health plan type was stratified into 4
groups: point of service (POS), preferred provider organiza-
tion (PPO), exclusive provider organization (EPO), and other.
The ratio of paid-to-allowed health care costs represented
the ‘‘richness,’’ or actuarial value, of the subjects’ health
plan benefit design. The actuarial value was calculated for
each employer and assigned to each member. The complex
medical condition flag was created to designate whether a
member had at least one of the following complex conditions
as determined by claims-based diagnoses or procedures dur-
ing the HRA pre period: cancer, end-stage renal disease, HIV/
AIDS, organ transplant, trauma, or mental disorders.
Propensity score weighting for selection
bias adjustment
Propensity score weighting was used to adjust for po-
tential selection bias to enhance the generalizability of these
findings to the broader population. The propensity score
adjustment process uses information about the demographic,
socioeconomic, and health status variables already described
that could potentially drive HRA completion. This infor-
mation was used to estimate the underlying probability of
completing 2 HRAs for each individual, and then that esti-
mated probability was used to create a weighting variable to
be applied to the data from those who completed 2 HRAs to
make them better resemble all employees regardless of the
number of HRAs that were completed. The value of the
weighting variable equals 1/predicted probability of com-
pleting 2 HRAs. These weighted analyses reduced threats to
external validity that are problematic in other studies that do
not adjust for response bias. The utility of propensity score
models to adjust for external validity threats are described
elsewhere.29 A practical application of these methods was
demonstrated in a recent publication evaluating the associ-
ations between health risks and health care expenditures.13
One can make inferences about the utility of the propensity
score approach by assessing the balance of measured member
characteristics between HRA repeaters and non-completers/
non-repeaters. This can be done by comparing the standard-
ized difference value for each covariate used in the propensity
score weighting and observing how balance improves after
weighting. Standardized difference values less than 0.10 in-
dicate successful balancing of each variable between those
who completed 2 HRAs and those who did not. If most
variables have standardized difference values less than 0.10
this helps ensure that the study sample more closely resembles
the overall population of HRA completers/non-completers/
non-repeaters, thereby increasing generalizability of the study
findings when weighted statistical analyses are used.30
Finally, as a sensitivity analysis for the effectiveness of
the propensity score weighting method, the research team
also applied a 2-stage residual inclusion method suggested
by Terza et al31 to adjust for selection bias. This method
uses a 2-step regression model that adjusts for the impact of
both measurable and nonmeasurable variables that may in-
fluence the likelihood of completing 2 HRAs. The Terza
et al method is similar to the propensity score method in that
both begin by using regression analyses to estimate rela-
tionships between completing 2 HRAs and the demographic
and other variables already mentioned. Rather than creating
a case weight for the subsequent health risk/health expen-
diture regression, however, the Terza et al approach uses the
residuals from the HRA completion regression as another
independent variable in the risk/cost regression.
Outcome health care expenditure variable
Changes in health care expenditures were calculated by
subtracting the individual’s baseline expenditures prior to
the first HRA from (1) the annual expenditures prior to the
second HRA, and (2) from the annual costs after the second
HRA for each of the 9 risk status change categories. The
resulting cost dfference variables were used as the depen-
dent variables for the weighted risk/cost regressions de-
scribed next.
Regression modeling
Propensity score weighted multiple regression analyses
were performed to measure the independent association
between the health care cost differences and each of the 9
risk status change categories, controlling for the impact of
all of the covariates mentioned. Generalized linear regres-
sion models with a gamma distribution and a log link
function were used to assess the association between risk
status changes and changes in health care expenditures.32
Individuals whose total annual expenditures exceeded the
97.5th percentile were excluded from the analyses to avoid
outlier values from heavily influencing the results.
Results
Sample characteristics
The study included 50,005 sample members when the
focus was on health care expenditure changes between the
year before the first HRA was taken and the year before
the second HRA was taken. Sample sizes were lower
(n= 37,559) when focusing on expenditure changes between
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the year before the first HRA was taken and the year after
the second HRA. The unweighted demographics, health
status, and other characteristics of sample members for these
2 sets of analyses were similar and are shown in Table 1.
The samples used in both analyses were predominantly
employees, females, white, and well educated. Their aver-
age age was about 44 years. Most members chose POS
health plans. Health risk characteristics of sample members
are shown in Table 2. For most risk factors there were
small changes over time in percentages of sample members
at high risk.
The results of propensity score weighting for response
bias are shown in Table 3. Prior to propensity score
weighting, repeat HRA completers were significantly older,
more likely to be an employee, to have been offered an HRA
incentive, and to be in a small or medium-sized organiza-
tion. HRA repeaters also were less likely to have a medical
plan that was a POS, PPO, or EPO. After propensity score
weighting, differences between repeat HRA completers and
non-completers/non-repeaters were minimized. Most vari-
ables had standardized differences less than 0.10, indicating
successful weighting. The many differences between the
repeat HRA completers and non-completers/non-repeaters
prior to weighting underscore the importance of this ad-
justment in order to make these results generalizable.
Tables 4 and 5 show the propensity score weighted chan-
ges in health care expenditures associated with each of the 9
risk status change categories, after controlling for demo-
graphics, medical plan type, health status, and baseline health
risks. Differences in health care costs from the year before the
first HRA to the year before the second HRA are shown in
Table 4. Differences in health care costs from baseline to the
year after the second HRA are shown in Table 5.
In both tables, health care expenditures are presented as
unadjusted differences (ie, prior to any regression analyses);
regression adjusted differences without any weighting; and
propensity score weighted regression adjusted differences.
Generally, the values are consistent regardless of the use of
these approaches. The Terza et al model to adjust for se-
lection bias provided nearly identical results when compared
to the propensity score weighted results and thus are not
shown but are available from the authors upon request. 31
As shown in Table 4, significantly higher health care ex-
penditures were associated with transitions to higher risk
status (ie, moving from low to medium, low to high, or
medium to high risk). Significant cost increases also were
observed when comparing the year before the first HRA to
the year after the second HRA was taken, when considering
those who moved from low to medium risk and those who
moved from low to high risk (Table 5). Conversely, those
who improved their risk status by moving to lower risk
categories (ie, from high to medium or high to low risk)
demonstrated smaller cost increases compared to those who
remained high risk. However, the changes in costs that were
associated with reductions in risk were not statistically sig-
nificant in either analysis. Finally, about 30% of the sample
included those who were always in the lowest risk group;
members of this group had the lowest increases in costs over
time. Overall, 19% improved their risk status, another 18%
moved to a higher risk status through the addition of risk
factors, 11% remained medium risk, and about 20% remained
high risk over the time period (Tables 4 and 5).
Discussion
Sample members in this study of repeat HRA completers
were from small, medium, and large employers. The shorter
term economic impact of risk status changes indicated
Table 1. Demographic, Health Plan, Health Status,
and Other Characteristics of HRA Repeaters
Sample Focused
on Year Before
the First HRA
and Year Before
the Second HRA
(n = 50,005)
Sample Focused
on Year Before
the First HRA
and Year After
the Second HRA
(n = 37,559)
(%) (%)
Sex
Female 54.6 54.6
Age
18 to 34 22.5 21.7
35 to 44 29.1 28.9
45 to 54 31.7 32.2
55 to 63 16.8 17.3
Race
White 77.3 77.5
Black 8.5 8.1
Hispanic 8.2 8.5
Asian 4.3 4.2
Other 1.7 1.8
Education
High School or less 19.4 18.8
Some College 27.2 27.1
College Grad 37.2 37.7
Grad School 16.3 16.4
Health Plan Type
POS 61.5 71.7
PPO 3.7 4.7
EPO 15.1 18.1
Other 19.6 5.4
Relationship
Employee 82.8 85.4
Client Size
Small (1–1000) 28.1 31.8
Medium (1000–9999) 41.2 49.0
Large (‡ 10,000) 14.5 15.1
Unknown Size 16.2 4.1
Have a Health Care
Claim
89.7 89.5
Complex Medical
Conditions
11.6 11.8
Offered an HRA
Incentive
25.3 28.7
Client Allowed to Paid
Ratio
0.81 0.81
CCI 0.24 0.24
Time Between HRAs
(days)
362.5 361.6
CCI, Charlson comorbidity index; EPO, exclusive provider
organization; HRA, health risk assessment; POS, point of service;
PPO, preferred provider organization.
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significant increases in health care expenditures associated
with those who transitioned from low risk to either medium
or high risk. These cost increases persisted and increased in
the year after the second HRA was completed. Although
smaller cost increases were directionally associated with
risk status improvement compared to those who remained
high risk (ie, moving from high risk to medium or low risk),
these cost changes were not significant. Regression adjust-
ment and adjustments for selection bias did not change these
conclusions. Thus, these results would indicate that the cost
savings potential associated with health management pro-
grams may be enhanced with an increased focus on the
avoidance of gaining more risks.
This analysis utilized 9 health risks commonly used in the
health promotion industry to estimate health status (eg, low,
medium, and high risk) in the population studied.10–12,15,18,27
In implementing a population health management strategy,
however, the research team included both moderate and high
severity criteria in defining each of the individual health risks.
This approach better stratifies the population for low- and
Table 2. Health Risk Changes Over Time
Sample Focused on Year Before
the First HRA and Year Before
the Second HRA (n= 50,005)
Sample Focused on Year Before
the First HRA and Year After
the Second HRA (n = 37,559)
First HRA Second HRA First HRA Second HRA
Health Risks (%) (%) Change (%) (%) Change
BMI
15.0–18.4 (underweight) 0.9 0.8 - 0.1 0.9 0.8 - 0.1
18.5–24.9 (normal) 33.7 33.6 - 0.1 32.4 32.4 0.0
25.0–29.9 (overweight) 36.1 36.4 0.3 36.1 36.3 0.2
30.0–39.9 (obese) 24.9 24.8 - 0.1 25.9 25.8 - 0.1
40.0–55.0 (morbidly obese) 4.4 4.4 0.0 4.7 4.7 0.0
Blood Pressure
SBP/DBP < 120/80mm Hg 50.1 45.2 - 4.9 49.5 44.4 - 5.0
SBP 120–139 or DBP 80–89mm Hg 39.7 44.9 5.2 40.0 45.5 5.4
SBP> 139 or DBP > 89mm Hg 10.2 9.9 - 0.3 10.5 10.1 - 0.4
Cholesterol
130–199mg/dL 78.4 77.3 - 1.1 78.0 76.9 - 1.1
200–239mg/dL 12.7 14.5 1.8 12.8 14.6 1.8
> 239mg/dL 8.9 8.3 - 0.7 9.2 8.5 - 0.7
Smoking
Never 69.6 67.7 - 1.9 69.8 67.8 - 2.0
Former 22.3 24.5 2.2 22.1 24.4 2.3
Current 8.0 7.8 - 0.3 8.1 7.8 - 0.3
Alcohol
> 14 drinks/wk (men); > 7 drinks/wk
(women)
3.0 2.8 - 0.2 2.9 2.7 - 0.2
Nutrition (Fruit/Veg/Fiber)
5–6 servings per day 16.2 16.5 0.3 15.9 16.3 0.4
3–4 servings per day 46.7 47.5 0.7 46.8 47.4 0.6
1–2 servings per day 35.2 34.5 - 0.6 35.4 34.8 - 0.6
Rarely/never 2.0 1.5 - 0.5 1.9 1.5 - 0.4
Stress Impacted Health
None 20.9 21.7 0.8 20.1 21.1 0.9
Hardly Any 40.1 40.3 0.2 40.3 40.3 0.0
Some 33.1 32.3 - 0.9 33.6 33.0 - 0.7
A Lot 5.9 5.7 - 0.2 5.9 5.7 - 0.2
Drug Use For Relaxation
Rarely/Never 86.6 86.2 - 0.3 86.5 86.3 - 0.3
Sometimes 4.0 4.0 0.0 4.0 4.0 0.0
Almost Every Day 9.5 9.8 0.3 9.5 9.8 0.3
Physical Activity
3 or more times per week 59.6 60.4 0.8 58.7 59.9 1.2
1–2 times per week 27.3 27.8 0.5 27.8 28.2 0.4
< 1 time per week 13.1 11.8 - 1.3 13.5 12.0 - 1.6
Count of Risk (Categories)
Low Risk (0–2 risks) 42.8 43.1 0.3 41.8 42.3 0.5
Moderate Risk (3 risks) 26.6 26.5 - 0.2 26.8 26.6 - 0.2
High Risk (4–9 risks) 30.6 30.4 - 0.2 31.5 31.1 - 0.3
BMI, body mass index; DBP, diastolic blood pressure; HRA, health risk assessment; SBP, systolic blood pressure.
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high-level interventions. The study population had access to
annual HRAs and a health communications program and
demonstrated a small but nonsignificant improvement in the
percentage (+ 0.3 percentage points) of individuals at low
risk over time. This net change in health status for the pop-
ulation reflects an overall 19% of the population that im-
proved their risk status, 18% who got worse (ie, added health
risks), and 63% who stayed at the same risk level. Edington’s
natural flow model detailed in Loeppke et al15 indicates an
expectation of a loss of 5 percentage points for those at low
risk, with 16% expected to improve their health status, 23%
to add health risks, and 61% to stay at the same risk levels.
Table 3. Propensity Score Weighting for Response Bias to Reduce Differences Between Those
Who Completed Two HRAs and Those Who Did Not to Enhance the Generalizability of Results
Before Propensity Score Weighting After Propensity Score Weighting
Year of Change
Characteristic
1 or 0 HRA
Completers
2 HRA
Completers
Standardized
Difference
1 or 0 HRA
Completers
2 HRA
Completers
Standardized
Difference
Sample Number 3,534,107 50,005 3,534,107 50,005
Age (years) 41.7 43.5 0.154 41.7 43.4 0.145
Age Groups (%)
18–34 31.1 22.5 0.196 31.0 25.9 0.114
35–44 24.1 29.1 0.112 24.2 26.2 0.046
45–54 25.6 31.7 0.136 25.6 27.9 0.052
55–64 19.2 16.8 0.063 19.2 20.0 0.022
Female (%) 51.8 54.6 0.056 51.8 53.0 0.023
Have a Health Care Claim (%) 87.5 89.7 0.070 87.6 88.8 0.039
Complex Medical Condition (%) 13.7 11.6 0.065 13.7 13.5 0.005
Medical Plan Type (%)
POS 70.4 61.5 0.187 70.2 71.3 0.023
EPO 16.9 15.1 0.049 16.9 13.4 0.098
PPO 5.0 3.7 0.062 5.0 7.5 0.104
Other 7.7 19.6 0.350 7.9 7.9 0.001
Offered an HRA Incentive (%) 20.2 25.3 0.120 20.3 36.8 0.372
Employee Status (% EE) 64.0 82.8 0.435 64.2 67.0 0.060
Employer Size (%)
< 1000 17.0 28.1 0.267 17.2 19.8 0.067
1000–9999 35.4 41.2 0.119 35.5 40.2 0.096
‡ 10,000 36.2 14.5 0.514 35.9 35.5 0.008
Unknown 11.4 16.2 0.140 11.5 4.6 0.255
EE, employee; EPO, exclusive provider organization; HRA, health risk assessment POS, point of service; PPO, preferred provider
organization.
Table 4. Changes in Health Care Expenditures Associated with Changes in Risks When Focusing
on the Year Before the First HRA Was Taken and the Year Before the Second HRA Was Taken (n = 50,005)
Annual Health Care Expenditures and Cost Differences
Time 1
Risk
Time 2
Risk N
Year
Before
First HRA
Cost ($)
Year
Before the
Second
HRA ($)
Unadjusted
Cost
Difference
($)
*Adjusted Cost
Difference, Without
Propensity Score
Weighting ($)
P
value
Adjusted Cost
Difference After
Propensity Score
Weighting ($)
P
value
High Risk High 10,131 4096 4346 250 239 Ref 235 Ref
N = 15,290 Medium 3624 3451 3550 99 149 0.35 120 0.24
Low 1535 3424 3589 165 121 0.39 170 0.64
Medium
Risk
High 3578 3259 3577 318 339 0.05 380 0.02
N = 13,319 Medium 5553 2734 2900 166 154 Ref 156 Ref
Low 4188 2715 2907 193 192 0.68 157 0.99
Low Risk High 1498 2905 3497 592 511 0.0006 725 <.0001
N = 21,396 Medium 4055 2662 2836 174 191 0.34 252 0.045
Low 15,843 2412 2526 114 118 Ref 99 Ref
*Adjusted for age, sex, race, education, all baseline risks, medical plan type, client-based paid/allowed ratio, elapsed time between
HRAs, baseline Charlson comorbidity index, complex medical conditions (during T1 and T2), client size, and employee status.
HRA, health risk assessment.
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This would indicate that a low intensity health management
program such as described in the present study can improve
on the natural flow by assisting individuals to maintain their
current health status and minimize transitions to higher risk
status.
Expanding health risk criteria to include moderate se-
verity better stratifies the population for interventions but
lessens the impact on medical expenditures at baseline and
in observed changes in medical expenditures with changes
in those health risks over time. This may partially explain
the results that risk reduction from high-risk status to me-
dium or low risk was associated with smaller cost increases
compared to those who remained high risk, but not actual
cost decreases. Slowing medical cost increases in the current
health economic environment could be considered a win—
even without actual cost decreases.
In addition, the impact of gaining and losing health risks
over time on health care expenditures has been demon-
strated elsewhere. For example, the impact of weight gain
on members of employer health plans has been associated
with significantly increased health care expenditures,19,25
whereas weight loss (even in successful weight loss pro-
grams) was not associated with health care cost reductions
within the next 2 years.16 In a large study by Carls et al,19
individual risk changes were tracked for 9 health risks over
3 years. Seven of the individual health risks that were re-
duced were not associated with lower health care expendi-
tures while alcohol reduction and smoking cessation were
associated with significantly increased costs. Haynes et al26
tracked 5 health risk transitions, confirming that individual
risk reductions and overall risk status improvement were not
associated with expected cost decreases over the time pe-
riod. In fact, several of the risks that were reduced were
associated with significant cost increases, as health issues
may have motivated the changes in lifestyle (eg, smoking
cessation, BP reduction).
The timing of health care cost changes relative to risk
status changes has less often been the focus of scientific
research studies. This study design increased the precision
of these calculations by using a baseline year prior to the
completion of the first HRA and then considered cost changes
from the baseline to the year prior to the second HRA, or
from the baseline to the year after the second HRA was
completed. The precision of the design confirmed the results
that significant increases in health care expenditures were
associated with increased risks documented in the year before
the second HRA and, furthermore, that these cost increases
were significantly sustained in the year after the second HRA.
In contrast, although health care expenditure increases were
minimized over time with risk reduction documented in the
year before the second HRA, these smaller cost increases
were not statistically significant either in the year before or
after the second HRA.
One of the issues often raised about analyses of rela-
tionships between changes in health risks and associated
changes in health expenditures is whether the results are
influenced by selection bias. If so, the results obtained may
not generalize to those people who complete fewer than 2
HRAs. In the present study, only about 2% of the employees
and spouses of interest completed 2 HRAs. To address this
concern, the research team tested 2 adjustment approaches.
One was based on propensity score weighting29; the other
was a more recently developed residual inclusion method31
that is suitable when nonlinear relationships may exist, such
as those between risks and costs. Both sets of results showed
a similar pattern of findings. The research team urges some
caution when interpreting these results because such a large
proportion of people had fewer than 2 HRAs, so the ad-
justments that were applied may not have worked as well as
would be the case if many more had completed 2 HRAs.
One of the strengths of this study is the large, diverse
sample, which came from multiple employers of all sizes.
Smaller employers often depend on the availability of
health programs from their health insurance providers
but represent a significant portion of the market and are
responsible for much of the recent growth in wellness
opportunities being presented to employees.1 To date, most
research studies evaluating the impact of health manage-
ment programs have focused on one or only a few large
employers. This study provides an important addition to
Table 5. Changes in Health Care Expenditures Associated with Changes in Risks When Focusing
on the Year Before the First HRA Was Taken and the Year After the Second HRA Was Taken (n= 37,559)
Annual Health Care Expenditures and Cost Differences
Time
1 Risk
Time
2 Risk N
Year
Before
First HRA
Cost ($)
Year
After the
Second
HRA ($)
Unadjusted
Cost
Difference
($)
*Adjusted Cost
Difference, Without
Propensity Score
Weighting ($)
P
value
Adjusted Cost
Difference After
Propensity Score
Weighting ($)
P
value
High Risk High 7830 4140 4665 525 492 Ref 445 Ref
N = 11,818 Medium 2796 3545 3852 307 394 0.42 348 0.42
Low 1192 3472 3694 222 233 0.13 278 0.32
Medium Risk High 2729 3305 3682 377 352 0.78 334 0.5100
N = 10,059 Medium 4183 2803 3174 371 386 Ref 415 Ref
Low 3147 2693 3049 356 358 0.81 371 0.69
Low Risk High 1137 3012 3731 718 618 0.008 877 <.0001
N = 15,682 Medium 3014 2630 3001 370 349 0.22 434 0.01
Low 11,531 2416 2632 216 231 Ref 197 Ref
*Adjusted for age, sex, race, education, all baseline risks, medical plan type, client-based paid/allowed ratio, elapsed time between
HRAs, baseline Charlson comorbidity index, complex medical conditions (during T1 and T2), client size, and employee status.
HRA, health risk assessment.
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the health promotion literature in that employees from
smaller companies (1–1000) are duly represented; they
accounted for 28% of the study sample.
Limitations to consider include that the study results were
based primarily on self-reported HRA data. Previous re-
search has established the reliability and validity of HRA
data, certainly for use in categorizing individuals into low-
risk or at-risk subgroups.33,34 A second limitation is that the
adjustments for selection bias may be imperfect. With only a
small proportion of people completing 2 HRAs, it is still
possible that some unmeasured variables may influence the
results and the ability to generalize to the entire population
still may be somewhat limited. A third limitation relates to
the relatively high level of education of this study cohort
(54% had at least a college degree), which may limit the
generalizability of these results to populations from other
employers.
A strength of this study is its large sample size of mem-
bers with repeat HRAs that included employees, spouses,
and significant others, associated with a wide range of em-
ployer sizes. A second strength is the use of the multivariate
modeling, which controlled for several relevant confounding
variables. A third strength is the adjustment for selection
bias, though, while not likely to be perfect, was at least
attempted and seems to be the first of its kind in this body of
literature.
The research team found that health risks significantly
affected health care expenditures across employers small
to large. Furthermore, as health risks increased, health
care expenditures significantly increased over time. These
results underscore the potential opportunities for cost
savings among employers of all sizes by focusing not
only on reducing behavioral risks in susceptible individu-
als but perhaps more importantly by assisting those cur-
rently low-risk individuals to maintain their low-risk status
over time.
Most insurance providers offer HRAs and other (eg, disease
management) program features, thus program opportunities
should be available across most employers either as employer-
funded health management programs or as a benefit for
those with insurance coverage. These results would indicate
that efforts to avoid future health risks, along with health
improvement opportunities, would be beneficial to em-
ployees in improved quality of life and well-being, and to
their employers in maximizing the potential of health
management programs as one strategy in the containment of
health care costs.
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